Cetera Investment Advisers
CRBU icon

Cetera Investment Advisers’s Caribou Biosciences CRBU Stock Holding History

Cetera Investment Advisers’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,781
Closed -$28.1K – 5045
2026
Q1 		$28.1K Sell
14,781
-1,000
-6% -$1.72K ﹤0.01% 4634
2025
Q4 		$25.1K Buy
15,781
+898
+6% +$1.89K ﹤0.01% 4564
2025
Q3 		$34.7K Buy
14,883
+2,229
+18% +$4.21K ﹤0.01% 4458
2025
Q2 		$15.9K Sell
12,654
-1,752
-12% -$1.72K ﹤0.01% 4035
2025
Q1 		$13.2K Sell
14,406
-1,374
-9% -$1.79K ﹤0.01% 3933
2024
Q4 		$25.1K Buy
15,780
+357
+2% +$718 ﹤0.01% 3697
2024
Q3 		$30.2K Buy
15,423
+2,480
+19% +$5.08K ﹤0.01% 3632
2024
Q2 		$21.2K Buy
+12,943
New +$41.4K ﹤0.01% 3648

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cetera Investment Advisers's CRBU Position: Q2 2026 in Review

Cetera Investment Advisers sold out of Caribou Biosciences (CRBU) in Q2 2026, closing a stake of 14,781 shares — an estimated $28.1K sold.

Cetera Investment Advisers first reported a position in CRBU in Q2 2024 and held it in 8 quarters. The position peaked at $34.7K in Q3 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Cetera Investment Advisers reported no remaining Caribou Biosciences position as of Q2 2026 after selling out during the quarter.
  • Cetera Investment Advisers sold 14,781 Caribou Biosciences shares in Q2 2026, an estimated $28.1K.
  • Cetera Investment Advisers first reported a position in Caribou Biosciences in Q2 2024 and held it in 8 quarters.
  • Cetera Investment Advisers's Caribou Biosciences position peaked at $34.7K in Q3 2025.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.